Clinical Trial Update: Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

View source ↗

Summary

Completed clinical trial assessing biomarkers to predict response to chemotherapy (carboplatin and paclitaxel) with or without sorafenib in advanced or metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nexavar (Sorafenib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Melanoma (Skin) | Status: COMPLETED